Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

28. december 2006 opdateret af: Pfizer

Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures.

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding

750

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Canada
    • Alberta
      • Calgary, Alberta, Canada, T2N 2T9
        • Pfizer Investigational Site
      • Edmonton, Alberta, Canada, T5G 0B7
        • Pfizer Investigational Site
      • Edmonton, Alberta, Canada, T5H 3V9
        • Pfizer Investigational Site
    • Ontario
      • Barrie, Ontario, Canada, L4M 4S5
        • Pfizer Investigational Site
      • London, Ontario, Canada, N6A 5A5
        • Pfizer Investigational Site
      • Toronto, Ontario, Canada, M5C 1R6
        • Pfizer Investigational Site
  • Forenede Stater
    • Arizona
      • Phoenix, Arizona, Forenede Stater, 85013
        • Pfizer Investigational Site
      • Tucson, Arizona, Forenede Stater, 85724
        • Pfizer Investigational Site
    • California
      • Bakersfield, California, Forenede Stater, 93301
        • Pfizer Investigational Site
      • Berkeley, California, Forenede Stater, 94705
        • Pfizer Investigational Site
      • Concord, California, Forenede Stater, 94520
        • Pfizer Investigational Site
      • Covina, California, Forenede Stater, 91723
        • Pfizer Investigational Site
      • El Cajon, California, Forenede Stater, 92021
        • Pfizer Investigational Site
      • Encino, California, Forenede Stater, 91436
        • Pfizer Investigational Site
      • La Mesa, California, Forenede Stater, 91942
        • Pfizer Investigational Site
      • Marina del Ray, California, Forenede Stater, 90292
        • Pfizer Investigational Site
      • Martinez, California, Forenede Stater, 94553
        • Pfizer Investigational Site
      • Northridge, California, Forenede Stater, 91325
        • Pfizer Investigational Site
      • Pinole, California, Forenede Stater, 94564
        • Pfizer Investigational Site
      • Redondo Beach, California, Forenede Stater, 90277
        • Pfizer Investigational Site
      • Sacramento, California, Forenede Stater, 95823
        • Pfizer Investigational Site
      • Sacramento, California, Forenede Stater, 95816
        • Pfizer Investigational Site
      • San Diego, California, Forenede Stater, 92120
        • Pfizer Investigational Site
      • Santa Monica, California, Forenede Stater, 90404
        • Pfizer Investigational Site
      • Walnut Creek, California, Forenede Stater, 94598
        • Pfizer Investigational Site
    • Colorado
      • Denver, Colorado, Forenede Stater, 80218
        • Pfizer Investigational Site
      • Englewood, Colorado, Forenede Stater, 80110
        • Pfizer Investigational Site
    • Connecticut
      • Danbury, Connecticut, Forenede Stater, 06810
        • Pfizer Investigational Site
    • Florida
      • Miami, Florida, Forenede Stater, 33173
        • Pfizer Investigational Site
      • Miami, Florida, Forenede Stater, 33176
        • Pfizer Investigational Site
      • Orlando, Florida, Forenede Stater, 32806
        • Pfizer Investigational Site
      • Tampa, Florida, Forenede Stater, 33609
        • Pfizer Investigational Site
    • Georgia
      • Atlanta, Georgia, Forenede Stater, 30322
        • Pfizer Investigational Site
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60611
        • Pfizer Investigational Site
      • Chicago, Illinois, Forenede Stater, 60612
        • Pfizer Investigational Site
      • Chicago, Illinois, Forenede Stater, 60640
        • Pfizer Investigational Site
    • Kentucky
      • Crestview Hills, Kentucky, Forenede Stater, 41017
        • Pfizer Investigational Site
      • Louisville, Kentucky, Forenede Stater, 40202
        • Pfizer Investigational Site
    • Louisiana
      • Ruston, Louisiana, Forenede Stater, 71270
        • Pfizer Investigational Site
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21287
        • Pfizer Investigational Site
    • Michigan
      • Detroit, Michigan, Forenede Stater, 48202-2689
        • Pfizer Investigational Site
    • Minnesota
      • Golden Valley, Minnesota, Forenede Stater, 55422
        • Pfizer Investigational Site
      • Minneapolis, Minnesota, Forenede Stater, 55422
        • Pfizer Investigational Site
    • Mississippi
      • Jackson, Mississippi, Forenede Stater, 39216
        • Pfizer Investigational Site
    • Missouri
      • St. Louis, Missouri, Forenede Stater, 63110
        • Pfizer Investigational Site
    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89102
        • Pfizer Investigational Site
      • Las Vegas, Nevada, Forenede Stater, 89106
        • Pfizer Investigational Site
    • New Hampshire
      • Concord, New Hampshire, Forenede Stater, 03301
        • Pfizer Investigational Site
      • Dover, New Hampshire, Forenede Stater, 03820
        • Pfizer Investigational Site
    • New Jersey
      • New Brunswick, New Jersey, Forenede Stater, 08903
        • Pfizer Investigational Site
      • New Brunswick, New Jersey, Forenede Stater, 08901
        • Pfizer Investigational Site
      • Ridgewood, New Jersey, Forenede Stater, 07450
        • Pfizer Investigational Site
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater, 87131
        • Pfizer Investigational Site
      • Albuquerque, New Mexico, Forenede Stater, 87131-5021
        • Pfizer Investigational Site
      • Albuquerque, New Mexico, Forenede Stater, 87131-5281
        • Pfizer Investigational Site
    • New York
      • Bronx, New York, Forenede Stater, 10467
        • Pfizer Investigational Site
      • Brooklyn, New York, Forenede Stater, 11203
        • Pfizer Investigational Site
      • New York, New York, Forenede Stater, 10021
        • Pfizer Investigational Site
    • North Carolina
      • Asheville, North Carolina, Forenede Stater, 28803
        • Pfizer Investigational Site
      • Asheville, North Carolina, Forenede Stater, 28806
        • Pfizer Investigational Site
      • Raleigh, North Carolina, Forenede Stater, 27607
        • Pfizer Investigational Site
      • Winston-Salem, North Carolina, Forenede Stater, 27103
        • Pfizer Investigational Site
      • Winston-Salem, North Carolina, Forenede Stater, 37103
        • Pfizer Investigational Site
    • Ohio
      • Cincinnati, Ohio, Forenede Stater, 45242
        • Pfizer Investigational Site
      • Cincinnati, Ohio, Forenede Stater, 45219
        • Pfizer Investigational Site
      • Columbus, Ohio, Forenede Stater, 43210
        • Pfizer Investigational Site
    • Oklahoma
      • Oklahoma City, Oklahoma, Forenede Stater, 73104-5068
        • Pfizer Investigational Site
    • Oregon
      • Medford, Oregon, Forenede Stater, 97504
        • Pfizer Investigational Site
      • Portland, Oregon, Forenede Stater, 97210
        • Pfizer Investigational Site
      • Portland, Oregon, Forenede Stater, 97201
        • Pfizer Investigational Site
      • Portland, Oregon, Forenede Stater, 97209
        • Pfizer Investigational Site
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forenede Stater, 19104
        • Pfizer Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
        • Pfizer Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater, 15212
        • Pfizer Investigational Site
      • Ridley Park, Pennsylvania, Forenede Stater, 19078
        • Pfizer Investigational Site
      • Upland, Pennsylvania, Forenede Stater, 19013
        • Pfizer Investigational Site
    • Rhode Island
      • Cranston, Rhode Island, Forenede Stater, 02920
        • Pfizer Investigational Site
    • Tennessee
      • Knoxville, Tennessee, Forenede Stater, 37916
        • Pfizer Investigational Site
      • Memphis, Tennessee, Forenede Stater, 38103
        • Pfizer Investigational Site
    • Texas
      • Dallas, Texas, Forenede Stater, 75216
        • Pfizer Investigational Site
      • Dallas, Texas, Forenede Stater, 75230
        • Pfizer Investigational Site
      • Dallas, Texas, Forenede Stater, 75243
        • Pfizer Investigational Site
      • Fort Worth, Texas, Forenede Stater, 76107
        • Pfizer Investigational Site
      • Fort Worth, Texas, Forenede Stater, 76107-2699
        • Pfizer Investigational Site
      • Houston, Texas, Forenede Stater, 77030
        • Pfizer Investigational Site
      • Houston, Texas, Forenede Stater, 77025
        • Pfizer Investigational Site
      • Houston, Texas, Forenede Stater, 77002
        • Pfizer Investigational Site
      • Lubbock, Texas, Forenede Stater, 79410
        • Pfizer Investigational Site
      • San Antonio, Texas, Forenede Stater, 78229
        • Pfizer Investigational Site
      • San Antonio, Texas, Forenede Stater, 78207
        • Pfizer Investigational Site
    • Virginia
      • Alexandria, Virginia, Forenede Stater, 22304
        • Pfizer Investigational Site
      • Alexandria, Virginia, Forenede Stater, 22311
        • Pfizer Investigational Site
      • Charlottesville, Virginia, Forenede Stater, 22908
        • Pfizer Investigational Site
      • Roanoke, Virginia, Forenede Stater, 24014
        • Pfizer Investigational Site
      • Roanoke, Virginia, Forenede Stater, 24016
        • Pfizer Investigational Site
      • Sterling, Virginia, Forenede Stater, 20165
        • Pfizer Investigational Site
    • Washington
      • Bellevue, Washington, Forenede Stater, 98004
        • Pfizer Investigational Site
      • Bellvue, Washington, Forenede Stater, 98004
        • Pfizer Investigational Site
      • Spokane, Washington, Forenede Stater, 99202
        • Pfizer Investigational Site
      • Spokane, Washington, Forenede Stater, 99204
        • Pfizer Investigational Site
    • West Virginia
      • Morgantown, West Virginia, Forenede Stater, 26507
        • Pfizer Investigational Site
    • Wisconsin
      • Marshfield, Wisconsin, Forenede Stater, 54449
        • Pfizer Investigational Site
      • Milwaukee, Wisconsin, Forenede Stater, 53226
        • Pfizer Investigational Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

12 år og ældre (Barn, Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Must have met the inclusion criteria for preceding double-blind study
  • Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

  • Cannot have absence seizures

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Sikkerhed Tolerabilitet

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Pfizer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. november 1999

Studieafslutning

1. juli 2005

Datoer for studieregistrering

Først indsendt

30. august 2005

Først indsendt, der opfyldte QC-kriterier

30. august 2005

Først opslået (Skøn)

1. september 2005

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

1. januar 2007

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

28. december 2006

Sidst verificeret

1. december 2006

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 1008-035

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner